Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 230 followers
Latest posts
Last updated 4 minutes ago
Human medicines European public assessment report (EPAR): Sugammadex Mylan, sugammadex, Date of authorisation: 15/11/2021, Revision: 5, Status: Authorised
9 minutes ago
Human medicines European public assessment report (EPAR): Sugammadex Mylan, sugammadex, Date of...
Human medicines European public assessment report (EPAR): Loargys, Pegzilarginase, Date of authorisation: 15/12/2023, Revision: 2, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Loargys, Pegzilarginase, Date of authorisation...
Human medicines European public assessment report (EPAR): Pregabalin Sandoz, pregabalin, Date of authorisation: 19/06/2015, Revision: 20, Status: Authorised
about 1 hour ago
Human medicines European public assessment report (EPAR): Pregabalin Sandoz, pregabalin, Date of...
Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation: 02/08/2009, Revision: 31, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation...
Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 29, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation...
Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation: 19/09/2005, Revision: 33, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagene maraleucel, Date of authorisation: 04/04/2022, Revision: 6, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagene maraleucel, Date of...
Human medicines European public assessment report (EPAR): Dapagliflozin Viatris, dapagliflozin, Date of authorisation: 24/03/2023, Revision: 4, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Dapagliflozin Viatris, dapagliflozin, Date of...
Human medicines European public assessment report (EPAR): Bydureon, exenatide, Date of authorisation: 17/06/2011, Revision: 27, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Bydureon, exenatide, Date of authorisation...
Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation: 10/11/2017, Revision: 12, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation...
Human medicines European public assessment report (EPAR): Praxbind, idarucizumab, Date of authorisation: 20/11/2015, Revision: 13, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Praxbind, idarucizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Orgovyx, relugolix, Date of authorisation: 29/04/2022, Revision: 11, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Orgovyx, relugolix, Date of authorisation...